undefined
The trademark NEAPHARMA was filed by NeaPharma BV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on September 15, 2020, and received one opposition filed on December 9, 2020 by NEOPHARMED GENTILI S.p.A. on (a) Art. 8(4), (b) Likelihood of confusion. the opponent was represented by CON LOR S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 9, 2020
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on March 3, 2024.
The Opposition with reference B 003136462 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on June 1, 2022 by the EUIPO. The Opposition with reference B 003136462 was rejected according to Article 8(1)(b) EUTMR with decision issued on February 22, 2024 by the EUIPO. The Appeal with reference B R0488/2024-4 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on November 24, 2024 by the EUIPO. The Appeal with reference B R1420/2022-4 was Other according to Article 8(1)(b) EUTMR with decision issued on June 6, 2023 by the EUIPO.